Journal of Clinical Virology
Volume 35, Issue 2 , Pages 121-129, February 2006

Increasing incidence of mumps in Scotland: Options for reducing transmission

  • Martin Donaghy

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow, Scotland G3 7LN, UK
  • ,
  • J. Claire Cameron

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow, Scotland G3 7LN, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 141 300 1191; fax: +44 141 300 1170.
  • ,
  • Vera Friederichs

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow, Scotland G3 7LN, UK
    • Department of Statistics and Modelling Science, University of Strathclyde, Livingstone Tower, Richmond Street, Glasgow, Scotland G1 1XT, UK

Accepted 23 September 2005. published online 15 November 2005.

Abstract 

Background

There has been a dramatic increase in mumps in Scotland since November 2003, with cases primarily in adolescents and young adults.

Objectives

This paper describes mumps epidemiology in Scotland, undertakes a risk assessment and considers option for reducing transmission.

Results

Mumps is primarily a risk for the 13–25 year age group, as they have neither been offered two routine doses of measles, mumps and rubella MMR vaccine, nor been exposed to wild virus. Transmission is facilitated by a high degree of social mixing, with enclosed settings (school, universities etc.) being higher risk. On the basis of susceptibility and risk of transmission, three categories of higher (17–20 years), intermediate (21–22; 15–16 years), and low (23–25; 13–14 years) risk were defined, all in higher risk enclosed settings. Herd immunity would be very difficult to achieve, as it would require unrealistically high MMR uptake (an additional 45–80% in 17–20 year olds). A risk management strategy of reducing transmission and decreasing the likelihood of outbreaks was therefore proposed. Action would be targeted at the higher risk group (17–20 years) in higher risk settings. Three options were considered: do nothing; opportunistic immunisation through GPs; a mass campaign. The ‘do nothing’ option was discounted. The preferred option was to alert GPs to the need to offer MMR vaccine to 17–20 year olds in higher risk settings. The rationale for this was that it had the lowest cost, avoided disruption to services, and primarily that it would reduce the probability of mumps transmission in higher risk settings.

Conclusions

The Chief Medical Officer issued a letter to all health professionals in Scotland encouraging them to offer MMR vaccine to 13–15 year olds, who had not previously received two doses, and particularly those aged 17–20 years in higher risk settings.

Keywords: Mumps, Measles–mumps–rubella vaccine, Disease outbreak/prevention and control

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1386-6532(05)00266-0

doi:10.1016/j.jcv.2005.09.009

Journal of Clinical Virology
Volume 35, Issue 2 , Pages 121-129, February 2006